20,683 Shares in CVS Health Corporation $CVS Bought by Tema Etfs LLC

by · The Markets Daily

Tema Etfs LLC purchased a new stake in CVS Health Corporation (NYSE:CVS – Free Report) during the 3rd quarter, Holdings Channel reports. The firm purchased 20,683 shares of the pharmacy operator’s stock, valued at approximately $1,559,000.

A number of other large investors also recently modified their holdings of CVS. Vanguard Group Inc. increased its position in shares of CVS Health by 1.7% in the second quarter. Vanguard Group Inc. now owns 120,399,131 shares of the pharmacy operator’s stock valued at $8,305,132,000 after acquiring an additional 2,063,737 shares during the last quarter. State Street Corp grew its stake in CVS Health by 1.4% in the second quarter. State Street Corp now owns 58,788,585 shares of the pharmacy operator’s stock valued at $4,055,237,000 after purchasing an additional 800,414 shares in the last quarter. Geode Capital Management LLC increased its position in shares of CVS Health by 2.4% during the 2nd quarter. Geode Capital Management LLC now owns 28,635,233 shares of the pharmacy operator’s stock worth $1,966,083,000 after purchasing an additional 675,824 shares during the last quarter. Invesco Ltd. increased its position in shares of CVS Health by 15.3% during the 2nd quarter. Invesco Ltd. now owns 23,532,479 shares of the pharmacy operator’s stock worth $1,623,270,000 after purchasing an additional 3,118,626 shares during the last quarter. Finally, Norges Bank acquired a new stake in shares of CVS Health in the 2nd quarter valued at approximately $1,358,698,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on CVS shares. Raymond James Financial boosted their target price on shares of CVS Health from $75.00 to $90.00 in a report on Friday, October 31st. Barclays upped their target price on shares of CVS Health from $87.00 to $93.00 and gave the company an “overweight” rating in a report on Wednesday, December 10th. Wells Fargo & Company reduced their price target on CVS Health from $103.00 to $102.00 and set an “overweight” rating for the company in a report on Thursday, November 13th. Argus boosted their price target on CVS Health from $80.00 to $91.00 and gave the stock a “buy” rating in a research report on Tuesday, November 4th. Finally, The Goldman Sachs Group raised their price objective on CVS Health from $93.00 to $95.00 and gave the company a “buy” rating in a research report on Wednesday, December 10th. Two analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $94.86.

Get Our Latest Stock Analysis on CVS Health

CVS Health Stock Performance

Shares of NYSE:CVS opened at $80.36 on Tuesday. The company’s 50 day simple moving average is $78.73 and its 200 day simple moving average is $74.02. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63. CVS Health Corporation has a 1 year low of $49.52 and a 1 year high of $85.15. The stock has a market capitalization of $102.02 billion, a price-to-earnings ratio of 211.49, a price-to-earnings-growth ratio of 0.74 and a beta of 0.48.

CVS Health (NYSE:CVS – Get Free Report) last issued its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.24. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The company had revenue of $102.87 billion for the quarter, compared to analyst estimates of $98.85 billion. During the same quarter last year, the company posted $1.09 EPS. The company’s revenue for the quarter was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, research analysts predict that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd will be paid a dividend of $0.665 per share. The ex-dividend date of this dividend is Thursday, January 22nd. This represents a $2.66 annualized dividend and a yield of 3.3%. CVS Health’s payout ratio is presently 700.00%.

About CVS Health

(Free Report)

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.

Featured Stories

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS – Free Report).